World Child Cancer

What World Child Cancer does

World Child Cancer is a UK-registered charity (charity number 1084729) and US-registered 501(c)(3) (EIN 46-0886328), founded in 2007 and headquartered in London with 11–50 employees. It improves cancer diagnosis, treatment, and palliative care for children in low- and middle-income countries, operating 13 programmes across Africa, Asia, and Central America including Ghana, Malawi, Cameroon, Sierra Leone, Nepal, Bangladesh, Myanmar, and Mexico. Core programmes are organised around four pillars: early and accurate diagnosis; treatment and care; child wellbeing and family support; and advocacy and communications. Named offerings include early-diagnosis awareness and referral pathway strengthening, healthcare professional training (including specialist nursing programmes and pediatric oncology fellowships), the MSc in Healthcare Play Therapy launched in Ghana, Ghana's National Paediatric Imaging Protocol, the Shared Care Network in Nepal and Cameroon, the Xploro interactive chemotherapy storybook, the Courageous Futures Scholarship for survivors, and standardised Burkitt Lymphoma treatment protocols.

The organisation operates a donation-based revenue model with no commercial pricing. Income is diversified across individual donations, recurring monthly giving, corporate partnerships (Amgen, The Wiggett Group, and others), foundation grants (UBS Optimus Foundation, Stavros Niarchos Foundation, Health Carousel Foundation, Else Kröner-Fresenius-Stiftung, Foundation S, The Light Fund, The Reed Foundation), UK Aid Match government funding, and fundraising events including the London Marathon, gala dinners, quizzes, and the Big Give Christmas Challenge. Strategic delivery is through direct engagement with named partner hospitals such as Queen Elizabeth Central Hospital (Malawi), Komfo Anokye and Korle Bu Teaching Hospitals (Ghana), B.P. Koirala Memorial Cancer Hospital (Nepal), and Yangon Children's Hospital (Myanmar), supported by policy engagement with WHO, St. Jude Children's Research Hospital, City Cancer Challenge, and UNICEF. The stated strategic goal is to help save one million lives by 2030.

The organisation has no proprietary technology product. Its digital surface consists of a website donation platform, newsletter system, and social channels (Facebook, X, LinkedIn, Instagram, YouTube). The Xploro storybook is a third-party interactive digital tool integrated into programme delivery. No AI/ML, API, SDK, or app-based product is evidenced. The CEO is Luke Thomas; the Chair of Trustees is Rachel Hollis (OBE, 2025). Notable 2025 recognitions include the SIOP Nursing Leadership Award (Dr Glenn Mbah) and participation in the 78th World Health Assembly.

Name

World Child Cancer

Legal name

World Child Cancer UK

Website

https://worldchildcancer.org

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

World Child Cancer is a London-headquartered international charity, founded 2007, that improves diagnosis, treatment, and palliative care for children with cancer in low- and middle-income countries across 13 programmes in Africa, Asia, and Central America, funded by donations, foundation grants, corporate partnerships, and UK Aid Match.

Ownership category

akta.pro rank

Product category

Nonprofit Pediatric Oncology Services

NAICS

Child and Youth Services (62411), Child and Youth Services (624110), Social Assistance (624), Individual and Family Services (6241)

SIC

Services-Social Services (8300), Services-Health Services (8000)

akta.pro primary industry

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

akta.pro secondary industries

Maternal, Child & Adolescent Health Administration (BPAIAJAJ), Pediatric Hospice & Palliative Care (HLADAHAI)

Keywords

• Childhood cancer care
• Pediatric oncology programs
• Nonprofit healthcare services
• Cancer treatment access
• Healthcare capacity building

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Individual Donations: Individual donors contribute through one-time and recurring donations via the organization's website and fundraising platform. The charity promotes monthly giving programs and direct donations.
2. Corporate Partnerships: Corporate partners including The Wiggett Group, AD Construction Group, Faithorn Farrell Timms, Greyline, RGE Services, Ian Williams LTD, PiLON, True Compliance, Devonshires, Bakery79, and Park Garage Group Plc provide financial support through sponsorship, cause-marketing partnerships, and event participation.
3. Foundation Grants: Foundation partners including UBS Optimus Foundation, Stavros Niarchos Foundation (SNF), Health Carousel Foundation, Else Kröner-Fresenius-Stiftung, Light Fund, Foundation S – My Child Matters, and The Reed Foundation provide grant funding for specific programs.
4. Government Funding: UK Government through UK Aid Match provides matched funding for programs, particularly in Ghana and Malawi.
5. Events and Campaigns: Fundraising events including London Marathon, Gala Dinners, Quizzes, Golf Days, Manchester Dinner, and seasonal campaigns like the Big Give Christmas Challenge generate revenue.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

World Child Cancer improves cancer diagnosis, treatment, and palliative care for children in low- and middle-income countries through locally-led programs and globally-connected initiatives. It supports 13 programs across Africa, Asia, and Latin America by funding healthcare professional training, supplying equipment and medicines, supporting patient/family wellbeing, and advocating for national childhood cancer control plans.

Product overview

World Child Cancer operates as a charitable organization rather than a traditional product company. Its offerings consist of programmatic interventions and support services focused on improving childhood cancer care in low- and middle-income countries. The core portfolio includes: early diagnosis programs that raise awareness of warning signs and strengthen referral pathways; treatment and care support providing training, equipment, and medicines to hospitals; child wellbeing and family support services including financial assistance, play therapy, and hospital-based schools; and advocacy initiatives to influence policy. Key named programs include the MSc in Healthcare Play Therapy (West Africa's first), the Xploro interactive chemotherapy storybook, the Courageous Futures scholarship program, the Shared Care Network in Nepal/Cameroon, the National Paediatric Imaging Protocol in Ghana, and standardized Burkitt Lymphoma treatment guidelines. These programs operate across 13 countries in Africa, Asia, and Latin America through locally-led initiatives and global partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

• Childhood Cancer Care Programs
• Healthcare Professional Training
• MSc in Healthcare Play Therapy
• Xploro Interactive Chemotherapy Storybook
• Courageous Futures Scholarship
• Shared Care Network

Quantifiable outcome

• 7,526 children helped in 2023
• +4 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

15 partnerships are on record, tiered secondary, flagship and core.

• CoinDeposecondaryGTM or Marketing Partner · 1 February 2025New partnership launched in 2025 to support World Child Cancer's mission.
• AmgenflagshipStrategic or Co-development Partner · 1 October 2023Long-term collaboration with Amgen transforming odds for children with Burkitt's Lymphoma and other cancers while strengthening healthcare systems. Amgen enabled the launch of a groundbreaking MSc in Healthcare Play Therapy in Ghana and supports survivorship programs through the Courageous Futures Scholarship.
• City Cancer Challenge (C/Can)coreStrategic or Co-development PartnerWorld Child Cancer works with C/Can initiative to strengthen breast cancer diagnostic capacity, including procurement of mammography and ultrasound equipment in Kumasi, Ghana.
• International Children's Palliative Care Network (ICPCN)coreStrategic or Co-development PartnerCollaboration to expand children's palliative care in Ghana, with 10 specialized sessions training 128 healthcare professionals in medical, psychosocial, and family-centred palliative care.
• University of GhanacoreStrategic or Co-development PartnerPartner in launching West Africa's first MSc in Healthcare Play Therapy, offering 20 scholarships for play therapists from sub-Saharan Africa.
• Ministry of Health GhanacoreStrategic or Co-development PartnerGovernment partner in developing national pediatric imaging protocols and childhood cancer care standards, including the MSc in Healthcare Play Therapy.
• University of Health and Allied Sciences (Ghana)coreStrategic or Co-development PartnerAcademic partner in West Africa's first MSc in Healthcare Play Therapy program.
• World Health Organization (WHO)flagshipStrategic or Co-development PartnerWorld Child Cancer engaged in WHO's Global Initiative for Childhood Cancer and launch phase of Global Platform for Access to Childhood Cancer Medicines. Participated in 78th World Health Assembly.
• St. Jude Children's Research HospitalcoreStrategic or Co-development PartnerCo-leads the Global Platform for Access to Childhood Cancer Medicines with WHO, with World Child Cancer supporting country-level implementation.
• XplorosecondaryTechnology or IntegrationProvides free interactive chemotherapy storybooks co-created with families, clinicians, and Child Life specialists to help children understand treatment. Available to World Child Cancer patients across multiple program countries.
• Ramesh Gupta Memorial TrustsecondaryStrategic or Co-development PartnerCollaboration on standardizing Burkitt Lymphoma treatment protocol in Nepal.
• Together Against Childhood CancersecondaryStrategic or Co-development PartnerPartner in mapping referral pathways and aligning protocols for Burkitt Lymphoma treatment in Nepal.
• ACT-4-ChildrensecondaryStrategic or Co-development PartnerCollaborative initiative uniting industry, medical community, and patient support organizations to close the survival gap for children with cancer.
• Nepal Childhood Cancer Alliance (NCCA)coreStrategic or Co-development PartnerUnites government, NGOs, WHO, UNICEF, and national stakeholders to strengthen early diagnosis, family support, and health system coordination in Nepal.
• UNICEFcoreStrategic or Co-development PartnerPartners in Nepal Childhood Cancer Alliance to support childhood cancer care.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• UNICEF: UN agency delivering children's health and welfare programs globally, including as a partner in the Nepal Childhood Cancer Alliance. Comparable in targeting children in LMICs but with a vastly broader mandate.
• American Lebanese Syrian Associated Charities (ALSAC): Fundraising and awareness organization for St. Jude. Comparable as a large, established pediatric cancer charity with global fundraising reach and direct overlap with World Child Cancer's program countries.
• Partners In Health: International health NGO providing care in resource-limited settings and partnering with local governments. Comparable as a health-systems-strengthening NGO operating across multiple LMICs with a focus on equity.
• American Cancer Society: Large-scale cancer-focused nonprofit with global health programs. Comparable in mission category but operates as a broad incumbent spanning research, advocacy, and patient support rather than specializing in pediatric oncology in LMICs.

Emerging players

• City Cancer Challenge (C/Can): World Child Cancer is an active partner, working with C/Can on breast cancer diagnostics in Kumasi, Ghana. Comparable as a multi-stakeholder global health initiative operating at the city and country level in LMICs.
• Together Against Childhood Cancer: Coalition partner of World Child Cancer on Burkitt Lymphoma treatment harmonization in Nepal. Comparable as an emerging multi-stakeholder initiative focused on closing the childhood cancer survival gap.
• Clinton Health Access Initiative (CHAI): Global health NGO that strengthens health systems and supply chains in LMICs. Comparable operating model of working with ministries of health, training workforces, and improving access to medicines.

Direct peers

• Childhood Cancer International: Global umbrella network of childhood cancer parent and survivor organizations. Closely comparable mission of improving survival and care for children with cancer worldwide through advocacy and member support.
• St. Jude Children's Research Hospital (including Global HOPE): Co-leads the Global Platform for Access to Childhood Cancer Medicines with WHO and operates Global HOPE in sub-Saharan Africa. Directly comparable as a pediatric cancer organization active in LMICs and a key World Child Cancer partner.
• International Society of Paediatric Oncology (SIOP): Global professional society for pediatric oncology that sets treatment standards and recently awarded World Child Cancer's Dr Glenn Mbah. Directly comparable as a stakeholder shaping pediatric oncology practice in LMICs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/WChildCancer
• YouTubeyoutube.com/@worldchildcancer
• Facebookfacebook.com/worldchildcancer
• LinkedInlinkedin.com/company/world-child-cancer
• Instagraminstagram.com/worldchildcancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about World Child Cancer